Table 1.
Patients’ clinical and pathological details.
| PD group (n = 85) | VR group (n = 21) | P value | |
|---|---|---|---|
| Age (y) | 63.5 ± 10.7 | 63.0 ± 7.5 | 0.83 |
| Sex (male/female) | 44/41 | 13/8 | 0.404 |
| TBil (µmol/L) | 125.7 ± 110.4 | 103.4 ± 110.9 | 0.409 |
| PV/SMV invasion (−/+) | 85/0 | 5/16 | Null |
| Tumour dimension (cm) | 2.8 ± 0.9 | 3.7 ± 0.6 | <0.01 |
| RLM (−/+) | 38/47 | 3/18 | 0.01 |
| Stage (IA/IB/IIA/IIB) | 17/17/4/47 | 0/1/2/18 | 0.021 |
| Resection (R0/R1/R2) | 60/19/6 | 14/5/2 | 0.91 |
| Blood loss (ml) | 731.8 ± 568.9 | 938.1 ± 664.4 | 0.153 |
| Duration of operation (min) | 407.0 ± 104.8 | 510.2 ± 146.2 | <0.01 |
| Complications (−/+) | 71/14 | 15/6 | 0.204 |
| Pancreatic fistula (n) | 7 | 3 | Null |
| Intra-abdominal bleeding (n) | 3 | 2 | Null |
| Abdominal infection (n) | 4 | 2 | Null |
| Delayed gastric emptying (n) | 2 | 1 | Null |
| Reoperation (−/+) | 79/6 | 18/3 | 0.287 |
| Mortality (−/+) | 83/2 | 20/1 | 0.551 |
| Adjuvant therapy (−/+) | 27/58 | 7/14 | 0.890 |
Portal vein, PV; SMV, superior mesenteric vein; RLM, regional lymph node metastasis; TBil, total bilirubin; PD group, pancreatoduodenectomy group; VR group, venous resection combined with pancreatoduodenectomy group.